O’Leary, Ben http://orcid.org/0000-0002-1092-9169
Hrebien, Sarah
Morden, James P.
Beaney, Matthew
Fribbens, Charlotte
Huang, Xin
Liu, Yuan
Bartlett, Cynthia Huang
Koehler, Maria
Cristofanilli, Massimo
Garcia-Murillas, Isaac
Bliss, Judith M.
Turner, Nicholas C.
Article History
Received: 19 July 2017
Accepted: 29 January 2018
First Online: 1 March 2018
Competing interests
: B.O’L. received research funding from Pfizer (Inst). M.B. purchased stock from Randox Laboratories. X.H., Y.L., C.H.B., and M.K. are Pfizer employees and have Pfizer stock. M.C. received honoraria from Agendia, Dompe Farmaceutici, Celgene, Pfizer and has a consulting or advisory role in Dompe Farmaceutici, Cynvenio Biosystems, and Newomics. J.M.B. received research funding from AstraZeneca (Inst), Pfizer (Inst), Janssen Cilag (Inst), Novartis (Inst), Roche (Inst), and Clovis Oncology (Inst). N.C.T. has a consulting or advisory role in Roche, Pfizer, Novartis, AstraZeneca, and received research funding from Pfizer (Inst), Roche (Inst), and AstraZeneca. The remaining authors declare no competing financial interests.